Over the past 12 months, 0 insiders at IO Biotech, Inc. filed 0 open-market SEC Form 4 transactions on IOBT: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 30, 25 | Heidi HunterDirector | BUY | 15.0K | $1.39 | $21K |
| Dec 23, 24 | Qasim Iftikhar AhmadChief Medical Officer | BUY | 31.4K | $0.85 | $27K |
| Dec 23, 24 | Devin Whittemore SmithGeneral Counsel | BUY | 12.0K | $0.81 | $10K |
| Dec 23, 24 | Amy SullivanChief Financial Officer | BUY | 10.3K | $0.83 | $9K |
| Dec 23, 24 | Mai-britt ZoccaChief Executive Officer | BUY | 12.5K | $0.81 | $10K |
| Jul 26, 24 | Novo Holdings A/sTenPercentOwner | SELL | 23.5K | $1.31 | $31K |
| Jul 25, 24 | Novo Holdings A/sTenPercentOwner | SELL | 51.5K | $1.33 | $69K |
| May 10, 24 | Novo Holdings A/sTenPercentOwner | SELL | 658.8K | $1.22 | $804K |
| Feb 9, 24 | Novo Holdings A/sTenPercentOwner | SELL | 658.8K | $1.50 | $988K |
| Nov 22, 23 | Brian BurkavageChief Accounting Officer | BUY | 5.0K | $1.04 | $5K |
| Nov 21, 23 | Brian BurkavageChief Accounting Officer | BUY | 5.0K | $0.99 | $5K |
| Aug 9, 23 | Novo Holdings A/sTenPercentOwner | BUY | 2.47M | $2.03 | $5.0M |
| Aug 9, 23 | Vivo Capital Ix, LlcTenPercentOwner | BUY | 3.16M | $1.90 | $6.0M |
| Mar 17, 23 | Amy SullivanChief Financial Officer | BUY | 25.0K | $2.32 | $58K |
| Nov 9, 21 | Claus A. AnderssonDirector | BUY | 75.0K | $14.00 | $1.1M |
| Nov 9, 21 | Hbm Healthcare Investments (cayman) Ltd.TenPercentOwner | BUY | 325.0K | $14.00 | $4.5M |
| Nov 9, 21 | Invest A/s LundbeckfondTenPercentOwner | BUY | 2.14M | $14.00 | $30.0M |
| Nov 9, 21 | Vanessa MalierDirector | BUY | 162.5K | $14.00 | $2.3M |
| Nov 9, 21 | Jack NielsenDirector | BUY | 650.0K | $14.00 | $9.1M |
| Nov 9, 21 | Novo Holdings A/sTenPercentOwner | BUY | 325.0K | $14.00 | $4.5M |
| Nov 9, 21 | Vivo Capital Fund Ix, L.p.TenPercentOwner | BUY | 650.0K | $14.00 | $9.1M |
Over the past 12 months, insiders at IO Biotech, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on IOBT, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market IOBT insider purchase in our data was $30.0M by Invest A/s Lundbeckfond, TenPercentOwner, filed on Nov 9, 21.
0 different insiders at IO Biotech, Inc. filed open-market SEC Form 4 transactions on IOBT over the last 12 months.
InsiderTape plots every IOBT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every IO Biotech, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →